Gastrointestinal Complications From Alcohol Increasing in Young People
By Lori Solomon HealthDay Reporter
WEDNESDAY, March 5, 2025 -- Gastrointestinal complications from alcohol are increasing among adolescents and young adults, according to a research letter published online Feb. 27 in JAMA Network Open.
Oril Chapman, M.D., from Queen’s University in Ontario, Canada, and colleagues described the epidemiology of incident emergency department or inpatient encounters for end-organ complications from alcohol among 11,508 adolescents and young adults (aged 13 to 39 years) from 2003 to 2021.
The researchers found that most identified cases were male (64 percent). Complications involving the pancreas were more frequent than liver-related complications (29 versus 19 percent), including acute pancreatitis (92 percent). The incidence of pancreatitis increased by 7 percent per year in men and 12 percent per year in women, while liver-related complications increased by 6 percent per year in men and 9 percent per year in women.
"These findings underscore the importance of gastroenterologists in caring for individuals with harmful alcohol use and support the integration of addiction medicine into gastroenterology training along with consideration for multidisciplinary gastroenterology-addiction medicine clinics," the authors write. "Future research to understand these observations and evaluations in other age groups is urgently needed."
One author disclosed financial ties to Olympus, Pendopharm, Vantage Endoscopy, and Pentax.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-06 06:00
Read more

- Work Context Linked to Cardiovascular Disease Risk Factors
- Climate Change Could Be Fueling Female Cancer Deaths
- Calorie Restrictions, Low-Fat Diets May Reduce Depressive Symptoms
- U.S. FDA Grants Approval for Jivi (Antihemophilic Factor (Recombinant), PEGylated-aucl) in Pediatric Patients 7 to Under 12 Years of Age With Hemophilia A
- Merck’s Investigational Zilovertamab Vedotin at 1.75 mg/kg Dose Plus Standard of Care Showed Promising Antitumor Activity, Including Complete Response Rate, in Patients With Relapsed/Refractory DLBCL in Phase 2 Portion of waveLINE-003 Trial
- Celltrion's Yuflyma (adalimumab-aaty) Receives FDA Interchangeability Designation for All Approved Dosage Forms and Strengths
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions